About us
Our mission
preventing renal failure after heart surgery
In Pleioflow, we develop and commercialize Innovative solutions for people fighting CardioVascular Disease.
We do it with Passion, Commitment and Dedication for the benefit of patients, Healthcare Systems and our Shareholders.

The problem
ACUTE KIDNEY FAILURE
Acute Kidney Injury (AKI) is often recognized late and can result in morbidity, mortality and increased cost of care.

PERCENTAGE OF PATIENTS
DEVELOPING ACUTE RENAL
FAILURE POSTOPERATIVELY
(600,000 AKI PATIENTS)
There Are More Than
2 MILLION PATIENTS
Around The World UNDERGOING
CARDIAC SURGERY
ON AN ANNUAL BASIS
PERCENTAGE OF PATIENTS
PERMANENTLY AFFECTED BY
RENAL FAILURE REQUIRING
LIFE-LONG DIALYSIS
4-6B $/year
TOTAL RENAL FAILURE COSTS ASSOCIATED WITH CARDIAC SURGERY
AVERAGE EXTRA COST OF CARE PER CARDIAC SURGERY AKI PATIENT
EXTRA COST ASSOCIATED WITH END STAGE RENAL FAILURE PER PATIENT

LENGTH OF STAY
2-3 times prolonged

HOSPITAL COSTS
2-3 times higher

RE-ADMISSIONS
2-3 times more
(in less than 30 days)

CHRONIC KIDNEY DISEASE
2-3 times worse

HOSPITAL MORTALITY
6-13 times higher